Behandlung des drohenden hämatologischen Rezidivs von Patienten mit MDS oder AML mit Azacitidin (Vidaza)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/11/2011 - 31/12/2015
Description
Keywords: Azacitidin
Funding identifier: 2010-022388-37
Funder / funding scheme:
- Other public funder
Project management at the University of Münster
| Stelljes, Matthias | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Applicants from the University of Münster
| Stelljes, Matthias | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |